Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
0.694
+0.018 (2.65%)
At close: Dec 20, 2024, 4:00 PM
0.708
+0.014 (1.97%)
After-hours: Dec 20, 2024, 4:46 PM EST
Verrica Pharmaceuticals Employees
Verrica Pharmaceuticals had 100 employees as of December 31, 2023. The number of employees increased by 78 or 354.55% compared to the previous year.
Employees
100
Change (1Y)
78
Growth (1Y)
354.55%
Revenue / Employee
$92,100
Profits / Employee
-$849,910
Market Cap
62.87M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
InterCure | 270 |
OptiNose | 132 |
VolitionRx | 110 |
IceCure Medical | 77 |
Immuneering | 68 |
Oncolytics Biotech | 29 |
PDS Biotechnology | 25 |
SELLAS Life Sciences Group | 16 |
VRCA News
- 12 days ago - Verrica Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 15 days ago - Verrica Pharmaceuticals Announces that Development Partner Torii Pharmaceutical Files New Drug Application of TO-208 the Treatment of Molluscum Contagiosum in Japan - GlobeNewsWire
- 4 weeks ago - Verrica Announces Pricing of $42.0 Million Public Offering - GlobeNewsWire
- 4 weeks ago - Verrica Announces Proposed Public Offering - GlobeNewsWire
- 7 weeks ago - Verrica Pharmaceuticals Inc. Investor Alert (NASDAQ: VRCA): Schubert Jonckheer & Kolbe LLP Investigating Potential Shareholder Claims Against the Company's Officers and Directors for Possible False Statements - PRNewsWire
- 2 months ago - Verrica Pharmaceuticals Announces Acceptance of Two Abstracts Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell Carcinoma at the 2024 Fall Clinical Dermatology Conference - GlobeNewsWire
- 2 months ago - VERRICA PHARMACEUTICALS INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Verrica Pharmaceuticals Inc. - VRCA - Business Wire
- 2 months ago - Verrica Pharmaceuticals Announces Restructuring of Commercial Organization - GlobeNewsWire